MDR Stock Overview
MedAdvisor Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
MedAdvisor Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.29 |
| 52 Week High | AU$0.34 |
| 52 Week Low | AU$0.16 |
| Beta | 0.61 |
| 1 Month Change | 16.00% |
| 3 Month Change | 0% |
| 1 Year Change | 20.83% |
| 3 Year Change | -14.71% |
| 5 Year Change | -27.32% |
| Change since IPO | -20.33% |
Recent News & Updates
Are Investors Undervaluing MedAdvisor Limited (ASX:MDR) By 44%?
Mar 20
Health Check: How Prudently Does MedAdvisor (ASX:MDR) Use Debt?
Dec 15Recent updates
Are Investors Undervaluing MedAdvisor Limited (ASX:MDR) By 44%?
Mar 20Health Check: How Prudently Does MedAdvisor (ASX:MDR) Use Debt?
Dec 15Health Check: How Prudently Does MedAdvisor (ASX:MDR) Use Debt?
Apr 20MedAdvisor (ASX:MDR) Is Carrying A Fair Bit Of Debt
Jun 29Increases to MedAdvisor Limited's (ASX:MDR) CEO Compensation Might Cool off for now
Nov 09Is MedAdvisor (ASX:MDR) A Risky Investment?
Oct 11Is MedAdvisor (ASX:MDR) Using Too Much Debt?
Mar 08MedAdvisor (ASX:MDR) Shareholders Have Enjoyed A 41% Share Price Gain
Feb 10What Can We Make Of MedAdvisor's (ASX:MDR) CEO Compensation?
Jan 18
The Non-Executive Chairman of the Board of MedAdvisor Limited (ASX:MDR), Christopher Ridd, Just Bought A Few More Shares
Dec 22What Kind Of Investors Own Most Of MedAdvisor Limited (ASX:MDR)?
Dec 18Here's Why We're Not Too Worried About MedAdvisor's (ASX:MDR) Cash Burn Situation
Nov 22Shareholder Returns
| MDR | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | 13.7% | -3.9% | -3.0% |
| 1Y | 20.8% | 52.4% | 3.9% |
Return vs Industry: MDR underperformed the Australian Healthcare Services industry which returned 52.4% over the past year.
Return vs Market: MDR exceeded the Australian Market which returned 3.9% over the past year.
Price Volatility
| MDR volatility | |
|---|---|
| MDR Average Weekly Movement | 9.0% |
| Healthcare Services Industry Average Movement | 8.1% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.2% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: MDR has not had significant price volatility in the past 3 months.
Volatility Over Time: MDR's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Rick Ratliff | www.medadvisorsolutions.com |
MedAdvisor Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom. The company provides MedAdvisor, an extension of the pharmacy, that enables the patient to order repeat prescriptions, and schedule vaccinations, etc; and THRiV, an omni-channel intelligent patient management platform, that enables individualized patient engagement through the community pharmacy. MedAdvisor Limited was incorporated in 2010 and is based in Camberwell, Australia.
MedAdvisor Limited Fundamentals Summary
| MDR fundamental statistics | |
|---|---|
| Market cap | AU$148.54m |
| Earnings (TTM) | -AU$9.03m |
| Revenue (TTM) | AU$109.43m |
1.5x
P/S Ratio-17.7x
P/E RatioIs MDR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDR income statement (TTM) | |
|---|---|
| Revenue | AU$109.43m |
| Cost of Revenue | AU$93.81m |
| Gross Profit | AU$15.62m |
| Other Expenses | AU$24.65m |
| Earnings | -AU$9.03m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.016 |
| Gross Margin | 14.27% |
| Net Profit Margin | -8.25% |
| Debt/Equity Ratio | 21.5% |
How did MDR perform over the long term?
See historical performance and comparison